Oral IgY antibodies neutralize pathogens and toxins at mucosal surfaces — without antibiotics, without resistance, and without disrupting the microbiome. A prevention‑first approach to chronic disease and infection.
OXIgYN delivers this capability in a field‑ready, chewable tablet format.
OXIgYN
Operational Readiness Platform⚔️ PREVENT
Proactive force protection against gastrointestinal breakdown
🛡️ SUSTAIN
Nutrition + immune antibodies in a single field platform
🎯 RESTORE
Reduce inflammatory burden & microbiome disruption
Gastrointestinal illness remains a silent readiness killer. Even in modern theaters, contaminated food, water, and operational stress impair gut integrity. Diarrhea, dehydration, fatigue, and cognitive decline rapidly degrade unit effectiveness.
Consequences: mission interruption, medical evacuation, antibiotic pressure, secondary spread. OXIgYN addresses the vulnerability before it cripples readiness.
Military organizations invest in protective gear, vaccines, and water purification — but the gut remains an overlooked frontier. OXIgYN provides a dual‑action countermeasure that aligns with proactive health economics.
🔬 IMMUNE PROTECTION
Egg‑derived IgY antibodies target specific gastrointestinal pathogens & toxins directly inside the gut lumen — no systemic side effects, no microbiome devastation.
⚡ NUTRITIONAL SUSTAINMENT
Each chewable tablet delivers protein, dextrose energy, and micronutrients. A true protect + sustain platform for extended field operations.
“Prevention is cheaper than treatment.” Replacing reactive medical logistics with pre‑exposure gut defense reduces downstream costs: less IV fluids, fewer antibiotics, lower evacuation rates, and preserved combat power.
- Chewable tablet – no water required
- No cold chain / shelf‑stable
- Lightweight & low logistical footprint
- Integrates into MREs, deployment kits, survival packs
- Scalable human‑grade manufacturing (cGMP)
- Rapid onset of protective antibodies in the gut
Emerging science links microbiome disruption, endotoxemia (lipopolysaccharides), and chronic low‑grade inflammation to long‑term health and performance degradation. OXIgYN supports:
This positions OXIgYN not only as a field countermeasure, but as a strategic asset for long‑duration deployments, naval operations, and remote garrisons.
“The true cost of gastrointestinal illness isn’t just a sick soldier — it’s a broken mission. Protecting the gut protects the force.”
- Reduced combat effectiveness
- Impaired decision-making & cognitive lag
- Increased antibiotic consumption → resistance risk
- Manpower rotation & replacement costs
- Mission delays & intelligence gaps
OXIgYN offers a preemptive solution. Half an egg (20 tablets) per day fortifies gut immunity, reduces endotoxin load, and helps maintain battle rhythm.
OXIgYN is built upon the MEGGABIOTICS™ oral antibody platform — hyperimmunized egg‑derived IgY technology, targeting pathogens directly. Unlike antibiotics, it preserves commensal flora and avoids resistance pressure.
✓ Phase 2 clinical history (C. difficile)
✓ Scalable biologics manufacturing
✓ Safe as food, effective as biologic
Resetting human health from the gut out. A new category in operational gut defense — not a supplement, but a force multiplier.